Appili Therapeutics Inc.
APLI.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.90M | -2.63M | -2.82M | -2.81M | -3.96M |
| Total Depreciation and Amortization | 10.00K | 9.60K | 10.10K | 10.20K | 8.90K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12M | 1.52M | 1.19M | 476.20K | 1.25M |
| Change in Net Operating Assets | 319.80K | 1.16M | 1.20M | 489.10K | 379.40K |
| Cash from Operations | -451.30K | 50.80K | -425.90K | -1.84M | -2.32M |
| Capital Expenditure | -1.70K | -1.20K | 0.00 | -22.10K | -24.40K |
| Sale of Property, Plant, and Equipment | 500.00 | 500.00 | 500.00 | 500.00 | -2.60K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.20K | -700.00 | 500.00 | -21.60K | -27.00K |
| Total Debt Issued | 400.00K | 400.00K | 550.00K | 300.00K | 2.80M |
| Total Debt Repaid | -122.30K | -122.80K | -116.00K | -96.40K | -93.40K |
| Issuance of Common Stock | -- | -- | -- | -- | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -74.20K | -79.00K | -81.20K | -81.60K | -376.00K |
| Cash from Financing | 148.70K | 144.00K | 258.80K | 91.60K | 1.72M |
| Foreign Exchange rate Adjustments | 2.60K | -800.00 | -200.00 | 0.00 | -1.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -301.40K | 193.10K | -166.90K | -1.77M | -621.00K |